A phase I/II clinical trial of preoperative short-course carbon-ion radiotherapy for patients with squamous cell carcinoma of the esophagus

Journal of Surgical Oncology

Volumn 105, Issue 8, 2012, Pages 750-755

  Akutsu, Yasunori ^a,b   Yasuda, Shigeo ^a,c   Nagata, Matsuo ^a,d   Izumi, Yosuke ^a,e   Okazumi, Shinichi ^a,f   Shimada, Hideaki ^a,g   Nakatani, Yukio ^a,b   Tsujii, Hirohiko ^a,c   Kamada, Tadashi ^a,c   Yamada, Shigeru ^a,c   Matsubara, Hisahiro ^a,b  

^a Investigators of the Working Group for Gastrointestinal Tumors   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d CHIBA CANCER CENTER   (Japan)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^f TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^g TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

carbon ion radiotherapy; esophageal cancer; heavy ion radiotherapy; neoadjuvant therapy; squamous cell carcinoma; surgery

Indexed keywords

ACUTE TOXICITY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVERSE OUTCOME; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CARBON ION RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPLETE RESPONSE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; FEMALE; HUMAN; MALE; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; CARBON RADIOISOTOPES; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; NEOPLASM GRADING; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; REMISSION INDUCTION; SURVIVAL RATE;

EID: 84861094352     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22127     Document Type: Article

References (34)

1. Ferlay J, Shin HR, Bray F, et al.: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (J Int Cancer) 2010; 127: 2893-2917.
2. Isono K, Sato H, Nakayama K,: Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991; 48: 411-420.
3. Akutsu Y, Matsubara H,: Perioperative management for the prevention of postoperative pneumonia with esophageal surgery. Ann Thorac Cardiovasc Surg 2009; 15: 280-285.
4. Okada T, Kamada T, Tsuji H, et al.: Carbon ion radiotherapy: Clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res 2010; 51: 355-364.
5. Ishikawa H, Tsuji H, Kamada T, et al.: Carbon ion radiation therapy for prostate cancer: Results of a prospective phase II study. Radiother Oncol: J Eur Soc Ther Radiol Oncol 2006; 81: 57-64. (Pubitemid 44512056)
6. Kato S, Ohno T, Tsujii H, et al.: Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2006; 65: 388-397.
7. Miyamoto T, Baba M, Yamamoto N, et al.: Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys 2007; 67: 750-758. (Pubitemid 46215886)
8. Kato H, Tsujii H, Miyamoto T, et al.: Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 2004; 59: 1468-1476. (Pubitemid 38954070)
9. Kanai T, Furusawa Y, Fukutsu K, et al.: Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. Radiat Res 1997; 147: 78-85. (Pubitemid 27014450)
10. Kanai T, Endo M, Minohara S, et al.: Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 1999; 44: 201-210. (Pubitemid 29186209)
11. Endo M, Koyama-Ito H, Minohara S, et al.: HIPLAN-A heavy ion treatment planning system at HIMAC. J Jpn Soc Ther Radiol Oncol 1996; 8: 231-238.
12. Minohara S, Kanai T, Endo M, et al.: Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47: 1097-1103. (Pubitemid 30345611)
13. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). In, 2006.
14. Japanese Society for Esophageal Diseases (ed): "Guide Lines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus." Tokyo: Kanehara, 1999.
15. van Heijl M, van Lanschot JJ, Koppert LB, et al.: Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg 2008; 8: 21.
16. Jin HL, Zhu H, Ling TS, et al.: Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. World J Gastroenterol 2009; 15: 5983-5991.
17. Burmeister BH, Smithers BM, Gebski V, et al.: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-668. (Pubitemid 41222756)
18. Wijnhoven BP, van Lanschot JJ, Tilanus HW, et al.: Neoadjuvant chemoradiotherapy for esophageal cancer: A review of meta-analyses. World J Surg 2009; 33: 2606-2614.
19. Courrech Staal EF, Aleman BM, Boot H, et al.: Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer. Br J Surg 2010; 97: 1482-1496.
20. Fiorica F, Di Bona D, Schepis F, et al.: Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis. Gut 2004; 53: 925-930. (Pubitemid 38824146)
21. Research Center of Charged Particle Therapy. National Institute of Radiological Sciences (ed): "Phase I/II clinical trial of preoperative heavy ion therapy for esophageal cancer (9502)." Chiba, 2000.
22. Akutsu Y, Matsubara H, Shuto K, et al.: Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients. World J Surg 2009; 33: 1002-1009.
23. Ozawa S, Tachimori Y, Baba M, et al.: Comprehensive Registry of Esophageal Cancer in Japan, 2003. Esophagus 2011; 8: 9-29.
24. Le Prise E, Etienne PL, Meunier B, et al.: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-1784. (Pubitemid 24101950)
25. Apinop C, Puttisak P, Preecha N,: A prospective study of combined therapy in esophageal cancer. Hepato-Gastroenterol 1994; 41: 391-393. (Pubitemid 24273251)
26. Jamieson GG, Mathew G, Ludemann R, et al.: Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004; 91: 943-947. (Pubitemid 39070806)
27. Kato K, Muro K, Minashi K, et al.: Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage ii-iii esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 2011; 81: 684-690.
28. Twine CP, Lewis WG, Morgan MA, et al.: The assessment of prognosis of surgically resected oesophageal cancer is dependent on the number of lymph nodes examined pathologically. Histopathology 2009; 55: 46-52.
29. Wilson M, Rosato EL, Chojnacki KA, et al.: Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res 2008; 146: 11-15. (Pubitemid 351442944)
30. Greenstein AJ, Litle VR, Swanson SJ, et al.: Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg 2008; 206: 239-246.
31. Akutsu Y, Matsubara H,: The significance of lymph node status as a prognostic factor for esophageal cancer. Surg Today 2011; 41: 1190-1195.
32. Miyata H, Yamasaki M, Takiguchi S, et al.: Pre- and post-therapy nodal status equally affects survival of patients with oesophageal squamous cell carcinoma receiving preoperative chemoradiation. Oncol Rep 2010; 23: 1331-1337.
33. Rice TW, Rusch VW, Ishwaran H, et al.: Cancer of the esophagus and esophagogastric junction: Data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer 2010; 116: 3763-3773.
34. Nishimaki T, Tanaka O, Ando N, et al.: Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg 1999; 68: 2059-2064. (Pubitemid 30027825)